Abstract
Summary
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
The global market for Sclerotherapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.
Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.
In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sclerotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Sclerotherapy.
The Sclerotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sclerotherapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sclerotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical
Segment by Type
Detergents
Osmotic Agents
Chemical Irritants
Segment by Application
Venous Disease
Gastrointestinal Bleeding
Bronchopleural Fistula
Cystic Disease
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Sclerotherapy in global and regional level.
Chapter 3: Detailed analysis of Sclerotherapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sclerotherapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
The global market for Sclerotherapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.
Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.
In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sclerotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Sclerotherapy.
The Sclerotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sclerotherapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sclerotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical
Segment by Type
Detergents
Osmotic Agents
Chemical Irritants
Segment by Application
Venous Disease
Gastrointestinal Bleeding
Bronchopleural Fistula
Cystic Disease
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Sclerotherapy in global and regional level.
Chapter 3: Detailed analysis of Sclerotherapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sclerotherapy revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Study Coverage
1.1 Sclerotherapy Product Introduction
1.2 Market by Type
1.2.1 Global Sclerotherapy Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Detergents
1.2.3 Osmotic Agents
1.2.4 Chemical Irritants
1.3 Market by Application
1.3.1 Global Sclerotherapy Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Venous Disease
1.3.3 Gastrointestinal Bleeding
1.3.4 Bronchopleural Fistula
1.3.5 Cystic Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sclerotherapy Market Size Estimates and Forecasts
2.2 Sclerotherapy Market Size by Region: 2023 Versus 2030
2.2.1 Global Sclerotherapy Revenue by Region: 2019-2024
2.2.2 Global Sclerotherapy Revenue Forecast by Region (2025-2030)
2.2.3 Global Sclerotherapy Revenue Market Share by Region (2019-2030)
3 Global Sclerotherapy by Company
3.1 Global Sclerotherapy Revenue by Company (2019-2024)
3.2 Global Sclerotherapy Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Sclerotherapy Companies around the World: Ranking by Revenue
3.3.2 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Sclerotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Sclerotherapy Companies Headquarters & Product Type
3.4.1 Sclerotherapy Companies Headquarters
3.4.2 Global Sclerotherapy Companies Product & Service
3.4.3 Date of International Companies Enter into Sclerotherapy Market
3.5 Global Sclerotherapy Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 BTG
4.1.1 BTG Company Information
4.1.2 BTG Description, Business Overview
4.1.3 BTG Sclerotherapy Products Offered
4.1.4 BTG Sclerotherapy Revenue and Gross Margin (2019-2024)
4.1.5 BTG Sclerotherapy Revenue by Product in 2023
4.1.6 BTG Sclerotherapy Revenue by Application in 2023
4.1.7 BTG Sclerotherapy Revenue by Geographic Area in 2023
4.1.8 BTG Recent Developments
4.2 Kreussler
4.2.1 Kreussler Company Information
4.2.2 Kreussler Description, Business Overview
4.2.3 Kreussler Sclerotherapy Products Offered
4.2.4 Kreussler Sclerotherapy Revenue and Gross Margin (2019-2024)
4.2.5 Kreussler Sclerotherapy Revenue by Product in 2023
4.2.6 Kreussler Sclerotherapy Revenue by Application in 2023
4.2.7 Kreussler Sclerotherapy Revenue by Geographic Area in 2023
4.2.8 Kreussler Recent Developments
4.3 LGM Pharma
4.3.1 LGM Pharma Company Information
4.3.2 LGM Pharma Description, Business Overview
4.3.3 LGM Pharma Sclerotherapy Products Offered
4.3.4 LGM Pharma Sclerotherapy Revenue and Gross Margin (2019-2024)
4.3.5 LGM Pharma Sclerotherapy Revenue by Product in 2023
4.3.6 LGM Pharma Sclerotherapy Revenue by Application in 2023
4.3.7 LGM Pharma Sclerotherapy Revenue by Geographic Area in 2023
4.3.8 LGM Pharma Recent Developments
4.4 Troikaa
4.4.1 Troikaa Company Information
4.4.2 Troikaa Description, Business Overview
4.4.3 Troikaa Sclerotherapy Products Offered
4.4.4 Troikaa Sclerotherapy Revenue and Gross Margin (2019-2024)
4.4.5 Troikaa Sclerotherapy Revenue by Product in 2023
4.4.6 Troikaa Sclerotherapy Revenue by Application in 2023
4.4.7 Troikaa Sclerotherapy Revenue by Geographic Area in 2023
4.4.8 Troikaa Recent Developments
4.5 Changan Tianyu group
4.5.1 Changan Tianyu group Company Information
4.5.2 Changan Tianyu group Description, Business Overview
4.5.3 Changan Tianyu group Sclerotherapy Products Offered
4.5.4 Changan Tianyu group Sclerotherapy Revenue and Gross Margin (2019-2024)
4.5.5 Changan Tianyu group Sclerotherapy Revenue by Product in 2023
4.5.6 Changan Tianyu group Sclerotherapy Revenue by Application in 2023
4.5.7 Changan Tianyu group Sclerotherapy Revenue by Geographic Area in 2023
4.5.8 Changan Tianyu group Recent Developments
4.6 Bioniche Pharma Group Ltd
4.6.1 Bioniche Pharma Group Ltd Company Information
4.6.2 Bioniche Pharma Group Ltd Description, Business Overview
4.6.3 Bioniche Pharma Group Ltd Sclerotherapy Products Offered
4.6.4 Bioniche Pharma Group Ltd Sclerotherapy Revenue and Gross Margin (2019-2024)
4.6.5 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Product in 2023
4.6.6 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Application in 2023
4.6.7 Bioniche Pharma Group Ltd Sclerotherapy Revenue by Geographic Area in 2023
4.6.8 Bioniche Pharma Group Ltd Recent Development
4.7 Omega Pharmaceuticals
4.7.1 Omega Pharmaceuticals Company Information
4.7.2 Omega Pharmaceuticals Description, Business Overview
4.7.3 Omega Pharmaceuticals Sclerotherapy Products Offered
4.7.4 Omega Pharmaceuticals Sclerotherapy Revenue and Gross Margin (2019-2024)
4.7.5 Omega Pharmaceuticals Sclerotherapy Revenue by Product in 2023
4.7.6 Omega Pharmaceuticals Sclerotherapy Revenue by Application in 2023
4.7.7 Omega Pharmaceuticals Sclerotherapy Revenue by Geographic Area in 2023
4.7.8 Omega Pharmaceuticals Recent Development
4.8 Angiodynamics
4.8.1 Angiodynamics Company Information
4.8.2 Angiodynamics Description, Business Overview
4.8.3 Angiodynamics Sclerotherapy Products Offered
4.8.4 Angiodynamics Sclerotherapy Revenue and Gross Margin (2019-2024)
4.8.5 Angiodynamics Sclerotherapy Revenue by Product in 2023
4.8.6 Angiodynamics Sclerotherapy Revenue by Application in 2023
4.8.7 Angiodynamics Sclerotherapy Revenue by Geographic Area in 2023
4.8.8 Angiodynamics Recent Development
4.9 ENDO-FLEX
4.9.1 ENDO-FLEX Company Information
4.9.2 ENDO-FLEX Description, Business Overview
4.9.3 ENDO-FLEX Sclerotherapy Products Offered
4.9.4 ENDO-FLEX Sclerotherapy Revenue and Gross Margin (2019-2024)
4.9.5 ENDO-FLEX Sclerotherapy Revenue by Product in 2023
4.9.6 ENDO-FLEX Sclerotherapy Revenue by Application in 2023
4.9.7 ENDO-FLEX Sclerotherapy Revenue by Geographic Area in 2023
4.9.8 ENDO-FLEX Recent Development
4.10 MTW ENDOSKOPIE
4.10.1 MTW ENDOSKOPIE Company Information
4.10.2 MTW ENDOSKOPIE Description, Business Overview
4.10.3 MTW ENDOSKOPIE Sclerotherapy Products Offered
4.10.4 MTW ENDOSKOPIE Sclerotherapy Revenue and Gross Margin (2019-2024)
4.10.5 MTW ENDOSKOPIE Sclerotherapy Revenue by Product in 2023
4.10.6 MTW ENDOSKOPIE Sclerotherapy Revenue by Application in 2023
4.10.7 MTW ENDOSKOPIE Sclerotherapy Revenue by Geographic Area in 2023
4.10.8 MTW ENDOSKOPIE Recent Development
4.11 Cook Medical
4.11.1 Cook Medical Company Information
4.11.2 Cook Medical Description, Business Overview
4.11.3 Cook Medical Sclerotherapy Products Offered
4.11.4 Cook Medical Sclerotherapy Revenue and Gross Margin (2019-2024)
4.11.5 Cook Medical Sclerotherapy Revenue by Product in 2023
4.11.6 Cook Medical Sclerotherapy Revenue by Application in 2023
4.11.7 Cook Medical Sclerotherapy Revenue by Geographic Area in 2023
4.11.8 Cook Medical Recent Development
5 Breakdown Data by Type
5.1 Global Sclerotherapy Revenue by Type (2019-2024)
5.2 Global Sclerotherapy Revenue Forecast by Type (2025-2030)
5.3 Sclerotherapy Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Sclerotherapy Revenue by Application (2019-2024)
6.2 Global Sclerotherapy Revenue Forecast by Application (2025-2030)
6.3 Sclerotherapy Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Sclerotherapy Market Size YoY Growth 2019-2030
7.2 North America Sclerotherapy Market Facts & Figures by Country (2019-2030)
7.3 North America Sclerotherapy Revenue by Type (2019-2024)
7.4 North America Sclerotherapy Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Sclerotherapy Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Sclerotherapy Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Sclerotherapy Revenue by Type (2019-2024)
8.4 Asia-Pacific Sclerotherapy Revenue by Application (2019-2024)
9 Europe
9.1 Europe Sclerotherapy Market Size YoY Growth 2019-2030
9.2 Europe Sclerotherapy Market Facts & Figures by Country (2019-2030)
9.3 Europe Sclerotherapy Revenue by Type (2019-2024)
9.4 Europe Sclerotherapy Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Sclerotherapy Market Size YoY Growth 2019-2030
10.2 Latin America Sclerotherapy Market Facts & Figures by Country (2019-2030)
10.3 Latin America Sclerotherapy Revenue by Type (2019-2024)
10.4 Latin America Sclerotherapy Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Sclerotherapy Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Sclerotherapy Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Sclerotherapy Revenue by Type (2019-2024)
11.4 Middle East and Africa Sclerotherapy Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Sclerotherapy Supply Chain Analysis
12.2 Sclerotherapy Key Raw Materials and Upstream Suppliers
12.3 Sclerotherapy Clients Analysis
12.4 Sclerotherapy Sales Channel and Sales Model Analysis
12.4.1 Sclerotherapy Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Sclerotherapy Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Sclerotherapy Distributors
13 Market Dynamics
13.1 Sclerotherapy Industry Trends
13.2 Sclerotherapy Market Drivers
13.3 Sclerotherapy Market Challenges
13.4 Sclerotherapy Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer